EP3764988A4 - Polypeptides de formation de gel - Google Patents
Polypeptides de formation de gel Download PDFInfo
- Publication number
- EP3764988A4 EP3764988A4 EP19768400.4A EP19768400A EP3764988A4 EP 3764988 A4 EP3764988 A4 EP 3764988A4 EP 19768400 A EP19768400 A EP 19768400A EP 3764988 A4 EP3764988 A4 EP 3764988A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- gel
- forming polypeptides
- polypeptides
- forming
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/585—Calcitonins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862643593P | 2018-03-15 | 2018-03-15 | |
PCT/US2019/022275 WO2019178359A1 (fr) | 2018-03-15 | 2019-03-14 | Polypeptides de formation de gel |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3764988A1 EP3764988A1 (fr) | 2021-01-20 |
EP3764988A4 true EP3764988A4 (fr) | 2022-04-20 |
Family
ID=67907279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19768400.4A Pending EP3764988A4 (fr) | 2018-03-15 | 2019-03-14 | Polypeptides de formation de gel |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3764988A4 (fr) |
CN (1) | CN111885999A (fr) |
WO (1) | WO2019178359A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2755815T3 (es) | 2016-09-13 | 2020-04-23 | Allergan Inc | Composiciones de toxina de Clostridium no proteicas estabilizadas |
CN110818790A (zh) * | 2019-10-31 | 2020-02-21 | 成都圣诺生物制药有限公司 | 一种替莫瑞林的制备方法 |
CN113577014B (zh) * | 2020-12-30 | 2023-03-24 | 广州图微科创生物科技有限公司 | 医疗器械、水凝胶及其制备方法与应用 |
CN114181284A (zh) * | 2021-11-17 | 2022-03-15 | 成都赛恩贝外科学研究院 | 纳米短肽drf3在药物、nk细胞载体和生物医学的应用 |
CN114214280B (zh) * | 2021-12-20 | 2022-11-29 | 南开大学 | 一种利用自组装多肽衍生物水凝胶培养细胞球体的方法、一种细胞球体及其应用 |
CN115925975A (zh) * | 2022-08-03 | 2023-04-07 | 山东大学 | 一种靶向肿瘤干细胞的car-mφ体内外编辑制备方法以及其应用 |
WO2024039670A1 (fr) | 2022-08-15 | 2024-02-22 | Dana-Farber Cancer Institute, Inc. | Anticorps anti-cldn4 et leurs méthodes d'utilisation |
CN116270974B (zh) * | 2023-03-09 | 2024-03-12 | 湖南大学 | 一种组合物、阿柏西普递送系统和制备方法 |
CN117511851B (zh) * | 2024-01-03 | 2024-03-26 | 中国肉类食品综合研究中心 | 水凝胶支架在细胞培育肉制备中的应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5958877A (en) * | 1995-05-18 | 1999-09-28 | Wimalawansa; Sunil J. | Method for counteracting vasospasms, ischemia, renal failure, and treating male impotence using calcitonin gene related peptide |
US5998367A (en) * | 1991-03-08 | 1999-12-07 | Amylin Corporation | Pramlintide pro H-amylin salts and compositions |
US20050261179A1 (en) * | 2002-10-04 | 2005-11-24 | The Government Of The United States Of America | Vasoregulating compounds and methods of their use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0308137A (pt) * | 2002-03-04 | 2005-01-04 | Sod Conseils Rech Applic | Formulações de droga de liberação constante contendo um peptìdeo veìculo |
CN102348715B (zh) * | 2009-02-03 | 2017-12-08 | 阿穆尼克斯运营公司 | 延伸重组多肽和包含该延伸重组多肽的组合物 |
CN105079783B (zh) * | 2014-05-22 | 2018-06-19 | 清华大学深圳研究生院 | 药物组合物及其制备方法和用途 |
DE102015000363A1 (de) * | 2015-01-20 | 2016-07-21 | Emc Microcollections Gmbh | Neue modular funktionalisierbare Peptid-Hydrogele |
CN109475604B (zh) * | 2016-02-09 | 2023-04-04 | 艾得佩索拉公司 | 长效型clr/ramp激动剂的配量和用途 |
CN107412150B (zh) * | 2017-07-16 | 2019-07-09 | 常州大学 | 一种用于包裹药物的多肽水凝胶的制备方法 |
-
2019
- 2019-03-14 EP EP19768400.4A patent/EP3764988A4/fr active Pending
- 2019-03-14 WO PCT/US2019/022275 patent/WO2019178359A1/fr active Application Filing
- 2019-03-14 CN CN201980019009.8A patent/CN111885999A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5998367A (en) * | 1991-03-08 | 1999-12-07 | Amylin Corporation | Pramlintide pro H-amylin salts and compositions |
US5958877A (en) * | 1995-05-18 | 1999-09-28 | Wimalawansa; Sunil J. | Method for counteracting vasospasms, ischemia, renal failure, and treating male impotence using calcitonin gene related peptide |
US20050261179A1 (en) * | 2002-10-04 | 2005-11-24 | The Government Of The United States Of America | Vasoregulating compounds and methods of their use |
Non-Patent Citations (3)
Title |
---|
ELGERSMA RONALD C. ET AL: "Synthesis and structural investigations of N-alkylated [beta]-peptidosulfonamide-peptide hybrids of the amyloidogenic amylin(20-29) sequence: implications of supramolecular folding for the design of peptide-based bionanomaterials", ORGANIC & BIOMOLECULAR CHEMISTRY, vol. 4, no. 19, 1 January 2006 (2006-01-01), pages 3587 - 3597, XP055866902, ISSN: 1477-0520, DOI: 10.1039/B606875H * |
See also references of WO2019178359A1 * |
SUTTER ET AL: "Recombinant gelatin hydrogels for the sustained release of proteins", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 119, no. 3, 22 May 2007 (2007-05-22), pages 301 - 312, XP022087330, ISSN: 0168-3659, DOI: 10.1016/J.JCONREL.2007.03.003 * |
Also Published As
Publication number | Publication date |
---|---|
WO2019178359A1 (fr) | 2019-09-19 |
EP3764988A1 (fr) | 2021-01-20 |
CN111885999A (zh) | 2020-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3856764A4 (fr) | Polypeptides de cytokine masqués | |
EP3803740A4 (fr) | Protection de chaîne de blocs | |
EP3801265A4 (fr) | Débitmètre urinaire | |
EP3764988A4 (fr) | Polypeptides de formation de gel | |
EP3784463A4 (fr) | Fluorosulfones | |
EP3813861A4 (fr) | Polypeptides associés à l'héparine et leurs utilisations | |
EP3802565A4 (fr) | Polypeptides | |
EP3721129A4 (fr) | Cryosphère | |
AU2019350356A1 (en) | Arginase1 polypeptides | |
EP3870698A4 (fr) | Polypeptides anti-pathogènes | |
EP3876716A4 (fr) | Support cryogénique | |
EP3834079A4 (fr) | Configuration à réponses multiples et à questions multiples | |
EP3760901A4 (fr) | Structure d'étanchéité | |
EP3898652A4 (fr) | Peptides ciblant les mitochondries | |
EP3858868A4 (fr) | Composition de polypeptide | |
EP3792349A4 (fr) | Macrocyclase peptidique | |
EP3871913A4 (fr) | Objet mobile | |
EP3787554A4 (fr) | Endoprothèse-greffe | |
EP3738602A4 (fr) | Cytocide | |
EP3608631A4 (fr) | Boussole | |
AU2018901430A0 (en) | Modified polypeptides | |
AU2018904117A0 (en) | Polypeptides and uses thereof | |
EP3791184A4 (fr) | Polypeptides immunoréactifs | |
EP3822397A4 (fr) | Complexe | |
AU2018101027A4 (en) | PadPay |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20201012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12P 21/02 20060101ALI20211215BHEP Ipc: A61K 47/42 20170101ALI20211215BHEP Ipc: A61K 38/16 20060101ALI20211215BHEP Ipc: A61K 9/06 20060101ALI20211215BHEP Ipc: A61K 9/00 20060101ALI20211215BHEP Ipc: C07K 7/06 20060101ALI20211215BHEP Ipc: C07K 14/47 20060101ALI20211215BHEP Ipc: C07K 14/585 20060101ALI20211215BHEP Ipc: C07K 14/575 20060101AFI20211215BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20220321 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12P 21/02 20060101ALI20220315BHEP Ipc: A61K 47/42 20170101ALI20220315BHEP Ipc: A61K 38/16 20060101ALI20220315BHEP Ipc: A61K 9/06 20060101ALI20220315BHEP Ipc: A61K 9/00 20060101ALI20220315BHEP Ipc: C07K 7/06 20060101ALI20220315BHEP Ipc: C07K 14/47 20060101ALI20220315BHEP Ipc: C07K 14/585 20060101ALI20220315BHEP Ipc: C07K 14/575 20060101AFI20220315BHEP |